3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
about
Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic NephropathyModulation of the mevalonate pathway by akt regulates macrophage survival and development of pulmonary fibrosisRosuvastatin protects against podocyte apoptosis in vitroBeneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosisEffects of Dangguibuxue decoction on rat glomerular mesangial cells cultured under high glucose conditionsStatins in the treatment of polycystic ovary syndrome.Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience.Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and NeckFluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathwaysStatins and prostate cancer risk: a case-control study.MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.Effects of statins on the risk of hepatocellular carcinomaEpac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathwayAcute tubular injury causes dysregulation of cellular cholesterol transport proteins.Cancer risk in HBV patients with statin and metformin use: a population-based cohort study.Statin-Based Palliative Therapy for Hepatocellular CarcinomaEvidence for statin therapy in polycystic ovary syndrome.Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatinDrug insight: Immunomodulatory effects of statins--potential benefits for renal patients?Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells.Effects of simvastatin on retinoic acid system in primary human endometrial stromal cells and in a chimeric model of human endometriosis.myo-Inositol Oxygenase Overexpression Accentuates Generation of Reactive Oxygen Species and Exacerbates Cellular Injury following High Glucose Ambience: A NEW MECHANISM RELEVANT TO THE PATHOGENESIS OF DIABETIC NEPHROPATHYInsights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damageA glimpse of various pathogenetic mechanisms of diabetic nephropathy.Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells.Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.Statins are Associated With a Reduced Risk of Brain Cancer: A Population-Based Case-Control Study.Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patientsSimvastatin protects against the development of endometriosis in a nude mouse modelPodocytes: the Weakest Link in Diabetic Kidney Disease?Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat.New insights into molecular mechanisms of diabetic kidney disease.Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.Pharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions.Rho kinase inhibition in diabetic kidney disease.Pleiotropic effects of statins: new therapeutic targets in drug design.Research review on the pharmacological effects of astragaloside IV.MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1.
P2860
Q26784039-3586875D-DFCF-463A-9123-60D67B3AF69CQ28385018-125D33FC-E109-417C-B4F7-522D35C91E19Q33372307-C6B46D04-4BE8-4316-A968-E25BDC24C4D2Q33650958-6B555170-98DE-4C4A-8101-C9ECA7DF0BCFQ33730927-C1FD4AA2-A995-4810-81DF-09C1485A8CB6Q33789151-2FB9D925-C3F0-47F8-8FF9-87C1C9EAE101Q34212843-E57B14B3-25B2-4DEE-A597-D208A1D8EEEEQ34369305-33E3ED3D-17C7-4857-8940-BE0C6C4A6406Q34408514-3A67B293-D067-4F2C-B962-DAF93543D7A2Q34433638-812729EE-46F8-42E5-849E-1816463E17B8Q34719895-02AC6FBB-1A77-4F7C-8B64-7DEE026C55BAQ34997752-9BB8440B-43AD-4B45-B5C2-C0BF964B1E17Q35235683-4B4FD235-8210-4F50-B0A3-BF0DDB123769Q35791601-2FEB538C-03E1-4B4A-9E55-844B5429A5E6Q36152361-B600B8A3-D862-4823-B58B-82B6F6E2E368Q36206887-4D56B31C-B669-4590-816C-065C5EA62D3BQ36327934-D3BAF760-4089-42DB-8E11-B37FEB735422Q36370581-1990948E-C791-4B62-BC49-2DA5D0CE6CCDQ36577189-ECAB2B24-836D-40EC-AD64-6D904112B0E1Q36658462-9DC53234-5656-4339-A505-315FE07B8737Q36663065-138F310F-7AC1-440D-8340-FDFEEFC24648Q36674645-960F49E7-A161-4812-B8E1-CF526C443339Q36891626-2A0C50B2-33BF-4C26-8545-DF03BB5DBCE1Q36941304-183EB04A-3BCA-4CD8-8294-16DC9EA70DC0Q36979205-8FBAB8AC-B092-457A-A09D-C4F9AA447B9DQ37079170-8924C65E-77EA-4A11-B98D-F574D1B2F7B0Q37179559-5A21A2BC-1793-4ADA-95E6-79D54AE501BEQ37206323-9E5A55A3-4382-4C51-ABA4-C8775B9B1F4FQ37256889-7332842B-F8B2-42BD-8185-E5A8F0BE819EQ37257551-F163D3AD-E92C-46E1-9E14-66CE72C51520Q37340690-201F6432-22E2-4457-9FC1-5F3D2F575D28Q37404727-3D593BA6-1C7C-44EB-9F23-5A027637B277Q37598306-A96B1E26-FE6F-4467-8B8E-EE53FB7309ADQ37644907-637360BA-CB63-4C38-BDE0-4B82DA8325CEQ37662217-B310EEB2-765A-4138-9D40-C9F7BB6630D1Q38089739-BEECD973-79A0-483D-9AEE-41461F67B7BCQ38117171-8A3CF296-C384-462D-AC41-7AF37B024A92Q38825843-8F64915E-E382-423E-A3B2-DDA8327F9FFEQ38938657-579209B1-FACE-4DBA-B06C-11D5800CB5C5Q38987204-07D5232C-83B4-4321-B5CC-A6DC4F40CFD6
P2860
3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@ast
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@en
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@nl
type
label
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@ast
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@en
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@nl
prefLabel
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@ast
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@en
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@nl
P2093
P2860
P356
P1476
3-Hydroxy-3-methylglutaryl CoA ...... ions for diabetic nephropathy.
@en
P2093
Atul Sahai
Carrie Philips
Farhad R Danesh
Lixia Zeng
Mehran M Sadeghi
Yashpal S Kanwar
P2860
P304
P356
10.1073/PNAS.122228799
P407
P577
2002-06-04T00:00:00Z